By Bo Erickson WASHINGTON (Reuters) – Former union leader Dan Osborn’s independent run for U.S. Senate in deeply Republican Nebraska has shown unexpected strength and if he pulls off an upset victory could make the Navy veteran a Washington wild card next year. A series of recent polls has shown Osborn within striking distance of …
Nebraska independent Dan Osborn could be poised to shake up US Senate Read More »
By Hyunsu Yim and Hyonhee Shin SEOUL (Reuters) – South Korea’s foreign ministry summoned the Russian ambassador in Seoul on Monday to protest over what it has called the sending of North Korean troops to Russia for deployment in Ukraine. The Kremlin declined to directly answer a query on whether North Korean troops were going …
South Korea summons Russian envoy to protest North Korea troop dispatch Read More »
By Bharath Rajeswaran and Hritam Mukherjee (Reuters) -Indian shares closed lower on Monday, as lacklustre earnings and another bout of profit-booking overpowered a post-results rally in top private lender HDFC Bank. The NSE Nifty 50 fell 0.29% to 24,781.1, while the BSE Sensex settled 0.09% lower at 81,151.27 points. They swung between gains of about …
Indian shares dip as dull earnings, profit-booking outweigh HDFC Bank’s boost Read More »
BEIJING/SHANGHAI (Reuters) – Ping An Insurance (Group) Co of China Ltd reported on Monday a 36.1% rise in net profit in the first nine months of the year, driven by growing investment returns and new policies sold as the economy recovers. The insurance company posted 119.18 billion yuan ($17 billion) in net profit, the Chinese …
China’s Ping An Insurance posts 36.1% rise in nine-month profit Read More »
By Aditya Soni (Reuters) -Microsoft will allow its customers to build autonomous artificial intelligence agents from next month, in its latest push to tap the booming technology amid growing investor scrutiny of its hefty AI investments. The company is positioning autonomous agents – programs that need little human intervention unlike chatbots – as “apps for …
Microsoft to let clients build AI agents for routine tasks from November Read More »
By Jaspreet Kalra MUMBAI (Reuters) – The Indian rupee declined to its weakest closing level on record on Monday but avoided sharper losses as likely intervention by the Reserve Bank of India (RBI) blunted the pressure from weakness in regional peers and persistent dollar outflows. The rupee closed at 84.0725 against the U.S. dollar, a …
Rupee slips to record closing low on outflows, weak Asia FX Read More »
By Steve Holland and Andrea Shalal NEW YORK/PHILADELPHIA (Reuters) – Republican presidential candidate Donald Trump will visit North Carolina on Monday amid concerns from his Republican allies that crippling damage from storm Helene will depress turnout in the battleground state’s conservative mountain regions. Democratic candidate Kamala Harris planned to campaign in Wisconsin, Michigan and Pennsylvania …
Trump to visit storm-hit North Carolina, Harris to campaign with Republican Liz Cheney Read More »
ISLAMABAD (Reuters) – Pakistan approved changes to the constitution on Monday, which included empowering parliament to pick the Supreme Court’s chief justice, drawing criticism from opposition parties who said it was an attempt to subvert the judiciary. Pakistan’s top court has become a battleground between the government and jailed former Prime Minister Imran Khan, ruling …
Pakistan empowers parliament to pick country’s top judge Read More »
By Anton Bridge TOKYO (Reuters) – U.S. investment firm KKR has extended by 10 working days the first stage of its tender to take Japanese IT services firm Fuji Soft private, it said in a filing on Monday. The extension comes after Bain Capital made a rival proposal to buy all the shares of Fuji …
KKR extends tender period for Fuji Soft to November Read More »
By Patrick Wingrove (Reuters) – Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound, including in the form of dissolvable tablets. The new lawsuits, which name Pivotal Peptides, MangoRx and Genesis Lifestyle Medicine of Nevada, …
Lilly sues online vendors, medical spa over copycat weight-loss drugs Read More »
